0001274737-23-000091.txt : 20230906 0001274737-23-000091.hdr.sgml : 20230906 20230906170534 ACCESSION NUMBER: 0001274737-23-000091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230831 FILED AS OF DATE: 20230906 DATE AS OF CHANGE: 20230906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABALLI JOHN CENTRAL INDEX KEY: 0001843113 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39049 FILM NUMBER: 231240002 MAIL ADDRESS: STREET 1: C/O DECIPHER BIOSCIENCES, INC. STREET 2: 6925 LUSK BLVD, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXAGEN INC. CENTRAL INDEX KEY: 0001274737 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1261 LIBERTY WAY CITY: VISTA STATE: CA ZIP: 92081 BUSINESS PHONE: (760) 560-1501 MAIL ADDRESS: STREET 1: 1261 LIBERTY WAY CITY: VISTA STATE: CA ZIP: 92081 FORMER COMPANY: FORMER CONFORMED NAME: EXAGEN DIAGNOSTICS INC DATE OF NAME CHANGE: 20031230 4 1 wk-form4_1694034315.xml FORM 4 X0508 4 2023-08-31 0 0001274737 EXAGEN INC. XGN 0001843113 ABALLI JOHN C/O EXAGEN INC. 1261 LIBERTY WAY VISTA CA 92081 1 1 0 0 President and CEO 0 Common Stock 2023-08-31 5 A 0 E 9803 2.142 A 449803 D Represents shares of common stock purchased through Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). /s/ Kamal Adawi, as attorney-in-fact 2023-09-06